A bioartificial liver to treat severe acute liver failure

scientific article

A bioartificial liver to treat severe acute liver failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00000658-199405000-00012
P932PMC publication ID1243186
P698PubMed publication ID8185403
P5875ResearchGate publication ID15014666

P2093author name stringL Sher
M McGrath
L Podesta
A Hoffman
F Villamil
J Rozga
A D Moscioni
E Morsiani
E LePage
G Woolf
P2860cites workTherapeutic plasmapheresis for liver failure after hepatectomyQ69403830
Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogelQ69403833
Hybrid bioartificial liver in hepatic failure: preliminary clinical reportQ69707073
Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlationQ70572811
Effects of serial resin hemoperfusion in fulminant hepatic failureQ71185633
Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitisQ93699085
Controlled trial of exchange-transfusion therapy in fulminant hepatitisQ93731472
Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membraneQ34474877
Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic EncephalopathyQ39117120
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysisQ39442228
Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathyQ39568662
Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cellsQ41090200
Acute and subacute fulminant hepatic failure: the role of liver transplantationQ43740566
Development of a hybrid bioartificial liverQ44265532
Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failureQ46350658
Improved liver function following treatment with an extracorporeal liver assist deviceQ47353027
Earlier charcoal haemoperfusion in fulminant hepatic failureQ48895106
Hepatic support with hepatocyte suspensions in a permeable membrane dialyzerQ50952965
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.Q51772704
Use of a novel bioartificial liver in a patient with acute liver insufficiency.Q52037739
Acute hepatic failure treated by cross circulation.Q52727765
False neurotransmitters and hepatic failure.Q53915012
Total blood washout and exchange. A valuable tool in acute hepatic coma and Reye's syndromeQ67560010
Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in ratsQ67938433
A new hybrid artificial liver using a combination of hepatocytes and biomatrixQ68202073
Development of bioartificial liver: bilirubin conjugation in Gunn ratsQ68782748
New method of hepatocyte transplantation and extracorporeal liver supportQ68899761
Treatment of acute hepatic coma by ex vivo baboon and human liver perfusionsQ69373022
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)538-44; discussion 544-6
P577publication date1994-05-01
P1433published inAnnals of SurgeryQ4767866
P1476titleA bioartificial liver to treat severe acute liver failure
P478volume219

Reverse relations

cites work (P2860)
Q30845184A biodialysis system for liver support tested in a porcine hepatic failure model
Q40818552A tightly regulated immortalized human fetal hepatocyte cell line to develop a bioartificial liver
Q34575268ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process
Q77777651An update on high-yield hepatocyte isolation methods and on the potential clinical use of isolated liver cells
Q44101006Analysis of Multivariables during Porcine Liver Digestion to Improve Hepatocyte Yield and Viability for Use in Bioartificial Liver Support Systems
Q55476379Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical Study.
Q28237883Artificial and bioartificial liver support
Q74616161Artificial liver
Q33949286Artificial liver support devices for fulminant liver failure
Q92323574Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature
Q73314605Biodialysis: a new liver support system
Q33692604Bioreactors for hybrid liver support: historical aspects and novel designs
Q35781240Cellular therapies for liver replacement
Q41622955Cerebral edema and intracranial pressure monitoring
Q24540124Clinical application of bioartificial liver support systems
Q44413698Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial
Q33866914Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs
Q73305017Effect of bioartificial liver in pigs with total ischemic liver failure
Q44216238Effect of ethanolamine on liver regeneration after 90% hepatectomy in rats
Q40360684Effectiveness of polyamidoamine dendrimers modified with tripeptide growth factor, glycyl-L-histidyl-L-lysine, for enhancement of function of hepatoma cells
Q36415556Effects of a bioartificial liver support system on acetaminophen induced acute liver failure canines.
Q48411037Effects of large-pore hemofiltration in a swine model of fulminant hepatic failure
Q33328652Efficacy and limitation of apheresis therapy in critical care
Q40894231Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver
Q40985888Evaluation of extracorporeal bioartificial liver devices
Q41513472Experimental research on TECA-I bioartificial liver support system to treat canines with acute liver failure
Q73438218Experimental xenotransplantation of fresh isolated and cryopreserved pig hepatocytes: a biochemical and morphological study
Q74452131Extracorporeal liver perfusion
Q40875080Extracorporeal liver support: cell-based therapy for the failing liver
Q33731099Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis
Q33540212Fulminant hepatic failure
Q40507204Functional activity of human hepatoma cells transfected with adenovirus-mediated hepatocyte nuclear factor (HNF)-4 gene
Q38554811Hepatocyte cell therapy in liver disease.
Q35578597Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications
Q81646877Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids
Q42059920How valid is emergency liver transplantation for acute liver necrosis in patients with multiple-organ failure?
Q40899786Immobilization of ligand-modified polyamidoamine dendrimer for cultivation of hepatoma cells
Q38901747Immortalization of Human Fetal Hepatocyte by Ectopic Expression of Human Telomerase Reverse Transcriptase, Human Papilloma Virus (E7) and Simian Virus 40 Large T (SV40 T) Antigen Towards Bioartificial Liver Support
Q35018059Improving the next generation of bioartificial liver devices
Q71867547Influence of Warm Ischemia on Isolation and Primary Culture of Hepatocytes from Rat Liver for a Hybrid Artificial Liver
Q46500091Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study
Q73305039Intrasplenic transplantation of immortalized human fetal hepatocytes prolongs the survival of 90% hepatectomized rats
Q45862646Liver stem cells: prospects for treatment of inherited and acquired liver diseases
Q40966829Liver transplantation and its long-term management in children
Q41622936Liver transplantation for fulminant hepatic failure: North American experience
Q74617427Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis
Q34015343Natural antibodies and the host immune responses to xenografts
Q40609212New directions in acute liver failure
Q44789617Pharmacokinetic considerations in development of a bioartificial liver
Q46141325Plasma separation for artificial liver support
Q74267311Polyurethane membrane as an efficient immobilization carrier for high-density culture of rat hepatocytes in the fixed-bed reactor
Q74480512Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients
Q36680260Renal dysfunction associated with liver transplantation
Q33762458Review article: liver support systems in acute hepatic failure
Q40851415Review article: the management of acute liver failure
Q74428921Role of plasmapheresis in the management of acute hepatic failure in children
Q73793494Semiautomatic macroencapsulation of large numbers of porcine hepatocytes by coextrusion with a solution of AN69 polymer
Q41073936Stimulation of liver functions in hierarchical co-culture of bone marrow cells and hepatocytes
Q40683796Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression
Q36304257Technology insight: liver support systems
Q41622946Timing and candidacy for transplantation in acute liver failure: the European experience
Q73850402Transplantation of cells in matrices for tissue regeneration
Q40986109Treatment of hepatic failure--1996: current concepts and progress toward liver dialysis.
Q77087308What progress with artificial livers?
Q41696788What should we expect from a bioartificial liver in fulminant hepatic failure?
Q77070950Xenotransplantation
Q73925431[Acute liver failure]
Q77346610[Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver]
Q75198763[Liver replacement therapy. Reliable indications in acute liver failure]

Search more.